PTCT PTC THERAPEUTICS, INC.
Nasdaq · SEC CIK 1070081 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $64.58M 73 sales by 13 insiders
- Filings on record
- 283 since 2021-07-12, latest 2026-09-18 17:20
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | — | $25.99M |
| Pauwels Eric | Chief BUSINESS Off | — | $7.48M |
| SCHMERTZLER MICHAEL | Dir | — | $6.31M |
| Boulding Mark Elliott | EVP AND CLO | — | $5.96M |
| Reeve Emma | Dir | — | $4.23M |
| Klein Matthew B. | CEO, Dir | — | $4.22M |
| Jacobson Allan Steven | Dir | — | $2.91M |
| Utter Christine Marie | SVP, CAO | — | $1.94M |
| Okey Stephanie | Dir | — | $1.46M |
| Smith Mary L. | Dir | — | $1.43M |
Transactions 392
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-19 | 2025-12-17+ | PTCT | Pauwels Eric | Chief BUSINESS Off | M - OptEx | $62.10 | +43.5K | 73.2K | +146% | +$2.70M |
| DM | 2025-12-19 | 2025-12-17+ | PTCT | Pauwels Eric | Chief BUSINESS Off | S - Sale+OE | $75.40 | -43.5K | 70.5K | -38% | -$3.28M |
| D | 2025-12-18 | 2025-12-16 | PTCT | SCHMERTZLER MICHAEL | Dir | M - OptEx | $30.86 | +24.0K | 155.3K | +18% | +$740.6K |
| D | 2025-12-05 | 2025-12-03 | PTCT | Reeve Emma | Dir | S - Sale+OE | $78.62 | -733 | 6,666 | -10% | -$57.6K |
| D | 2025-12-05 | 2025-12-03 | PTCT | Reeve Emma | Dir | M - OptEx | $46.54 | +733 | 7,399 | +11% | +$34.1K |
| 2025-12-03 | 2025-12-01 | PTCT | Klein Matthew B. | CEO, Dir | A - Grant | $0.00 | +15.6K | 353.4K | +5% | $0 | |
| 2025-12-03 | 2025-12-02 | PTCT | Klein Matthew B. | CEO, Dir | S - Sale | $79.07 | -3,428 | 350.0K | -1.0% | -$271.1K | |
| DM | 2025-11-26 | 2025-11-24+ | PTCT | Jacobson Allan Steven | Dir | M - OptEx | $14.88 | +26.0K | 25.4K | New | +$386.9K |
| DM | 2025-11-26 | 2025-11-24+ | PTCT | Jacobson Allan Steven | Dir | S - Sale+OE | $82.00 | -26.0K | 19.0K | -58% | -$2.13M |
| DM | 2025-11-26 | 2025-11-25 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | M - OptEx | $30.75 | +71.9K | 112.0K | +179% | +$2.21M |
| DM | 2025-11-26 | 2025-11-25 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | S - Sale+OE | $83.44 | -71.9K | 102.2K | -41% | -$6.00M |
| DM | 2025-11-26 | 2025-11-24 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | M - OptEx | $30.23 | +35.6K | 106.7K | +50% | +$1.08M |
| DM | 2025-11-26 | 2025-11-24 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | S - Sale+OE | $80.18 | -35.6K | 100.6K | -26% | -$2.85M |
| D | 2025-11-25 | 2025-11-21 | PTCT | Reeve Emma | Dir | M - OptEx | $51.16 | +10.0K | 16.7K | +150% | +$511.6K |
| D | 2025-11-25 | 2025-11-21 | PTCT | Reeve Emma | Dir | S - Sale+OE | $79.50 | -10.0K | 6,666 | -60% | -$795.0K |
| 2025-11-21 | 2025-11-20 | PTCT | Okey Stephanie | Dir | G - Gift | $0.00 | -867 | 8,000 | -10% | $0 | |
| DM | 2025-11-19 | 2025-11-17 | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $75.99 | -2,812 | 103.9K | -3% | -$213.7K |
| D | 2025-11-19 | 2025-11-17 | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $25.69 | +2,812 | 106.7K | +3% | +$72.2K |
| D | 2025-11-14 | 2025-11-12 | PTCT | Reeve Emma | Dir | M - OptEx | $46.54 | +7,333 | 14.0K | +110% | +$341.3K |
| D | 2025-11-14 | 2025-11-12 | PTCT | Reeve Emma | Dir | S - Sale+OE | $74.50 | -7,333 | 6,666 | -52% | -$546.3K |
| DM | 2025-10-31 | 2025-10-30 | PTCT | Reeve Emma | Dir | S - Sale+OE | $69.50 | -15.7K | 6,666 | -70% | -$1.09M |
| D | 2025-10-31 | 2025-10-30 | PTCT | Reeve Emma | Dir | M - OptEx | $38.10 | +12.0K | 18.7K | +180% | +$457.2K |
| DM | 2025-10-09 | 2025-10-07 | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $63.43 | -3,375 | 104.2K | -3% | -$214.1K |
| D | 2025-10-09 | 2025-10-07 | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $38.10 | +3,375 | 107.3K | +3% | +$128.6K |
| D | 2025-10-07 | 2025-10-03 | PTCT | Jacobson Allan Steven | Dir | M - OptEx | $30.86 | +12.0K | 29.5K | +69% | +$370.3K |
| D | 2025-10-07 | 2025-10-03 | PTCT | Jacobson Allan Steven | Dir | S - Sale+OE | $65.00 | -12.0K | 17.5K | -41% | -$780.0K |
| DM | 2025-10-07 | 2025-10-03 | PTCT | Reeve Emma | Dir | S - Sale+OE | $65.96 | -25.6K | 12.7K | -67% | -$1.69M |
| DM | 2025-10-07 | 2025-10-03 | PTCT | Reeve Emma | Dir | M - OptEx | $35.73 | +25.6K | 20.3K | New | +$913.3K |
| DM | 2025-10-07 | 2025-10-03 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | M - OptEx | $30.86 | +55.0K | 152.2K | +57% | +$1.70M |
| DM | 2025-10-07 | 2025-10-03 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | S - Sale+OE | $66.05 | -55.0K | 100.6K | -35% | -$3.63M |
| DM | 2025-10-07 | 2025-10-03+ | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $39.42 | +24.9K | 122.0K | +26% | +$982.4K |
| DM | 2025-10-07 | 2025-10-03+ | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $65.75 | -24.9K | 103.9K | -19% | -$1.64M |
| DM | 2025-09-16 | 2025-09-11 | PTCT | Reeve Emma | Dir | M - OptEx | $26.30 | +10.8K | 20.3K | +114% | +$285.0K |
| DM | 2025-09-16 | 2025-09-11 | PTCT | Reeve Emma | Dir | S - Sale+OE | $59.50 | -15.7K | 10.3K | -60% | -$934.4K |
| DM | 2025-09-15 | 2025-09-11+ | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $61.18 | -47.2K | 103.9K | -31% | -$2.89M |
| DM | 2025-09-15 | 2025-09-11+ | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $38.10 | +47.2K | 104.8K | +82% | +$1.80M |
| D | 2025-09-11 | 2025-09-09 | PTCT | SOUTHWELL DAVID P | Dir | S - Sale+OE | $58.34 | -12.0K | 16.9K | -42% | -$700.1K |
| D | 2025-09-11 | 2025-09-09 | PTCT | SOUTHWELL DAVID P | Dir | M - OptEx | $30.86 | +12.0K | 28.9K | +71% | +$370.3K |
| DM | 2025-09-09 | 2025-09-08 | PTCT | Pauwels Eric | Chief BUSINESS Off | M - OptEx | $22.74 | +39.9K | 78.9K | +102% | +$906.2K |
| DM | 2025-09-09 | 2025-09-08 | PTCT | Pauwels Eric | Chief BUSINESS Off | S - Sale+OE | $56.92 | -39.9K | 72.9K | -35% | -$2.27M |
| 2025-09-02 | 2025-08-28 | PTCT | Jacobson Allan Steven | Dir | S - Sale | $50.15 | -1,667 | 17.5K | -9% | -$83.6K | |
| D | 2025-08-19 | 2025-08-15 | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $48.58 | -2,813 | 103.9K | -3% | -$136.7K |
| D | 2025-08-19 | 2025-08-15 | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $25.69 | +2,813 | 106.7K | +3% | +$72.3K |
| 2025-08-05 | 2025-08-05 | PTCT | Klein Matthew B. | CEO, Dir | S - Sale | $51.74 | -10.7K | 337.8K | -3% | -$555.6K | |
| 2025-08-05 | 2025-08-01 | PTCT | Klein Matthew B. | CEO, Dir | A - Grant | $0.00 | +75.0K | 348.5K | +27% | $0 | |
| 2025-07-17 | 2025-07-15 | PTCT | Gravier Pierre | CFO | S - Sale | $49.46 | -2,516 | 71.9K | -3% | -$124.4K | |
| DM | 2025-05-19 | 2025-05-15+ | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $46.13 | -2,812 | 103.9K | -3% | -$129.7K |
| DM | 2025-05-19 | 2025-05-15+ | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $25.69 | +2,812 | 105.8K | +3% | +$72.2K |
| 2025-04-24 | 2025-04-22 | PTCT | Klein Matthew B. | CEO, Dir | S - Sale | $48.74 | -2,804 | 273.2K | -1% | -$136.7K | |
| 2025-04-04 | 2025-04-02 | PTCT | Golden Lee Scott | EVP, Chief MEDICAL Off | S - Sale | $46.95 | -897 | 76.0K | -1% | -$42.1K | |
| M | 2025-03-18 | 2025-03-14+ | PTCT | Pauwels Eric | Chief BUSINESS Off | S - Sale | $56.16 | -11.2K | 76.3K | -13% | -$630.1K |
| 2025-03-17 | 2025-03-13 | PTCT | Okey Stephanie | Dir | S - Sale | $54.00 | -5,000 | 8,867 | -36% | -$270.0K | |
| DM | 2025-03-14 | 2025-03-12 | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $33.02 | +15.5K | 106.3K | +17% | +$512.5K |
| DM | 2025-03-14 | 2025-03-12 | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $53.30 | -15.5K | 103.9K | -13% | -$827.2K |
| DM | 2025-03-12 | 2025-03-10+ | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $53.08 | -75.4K | 103.9K | -42% | -$4.00M |
| DM | 2025-03-12 | 2025-03-10+ | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $31.93 | +75.4K | 115.2K | +190% | +$2.41M |
| 2025-03-06 | 2025-03-04 | PTCT | Jacobson Allan Steven | Dir | S - Sale | $51.52 | -1,230 | 19.1K | -6% | -$63.4K | |
| M | 2025-02-21 | 2025-02-19+ | PTCT | Gravier Pierre | CFO | S - Sale | $50.11 | -2,335 | 74.4K | -3% | -$117.0K |
| MI | 2025-02-21 | 2025-02-19+ | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | S - Sale | $50.11 | -68 | 5,941 | -1% | -$3,407 |
| M | 2025-02-21 | 2025-02-19+ | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | S - Sale | $50.11 | -2,878 | 101.9K | -3% | -$144.2K |
| M | 2025-02-21 | 2025-02-19+ | PTCT | Utter Christine Marie | SVP, CAO | S - Sale | $50.11 | -1,757 | 63.4K | -3% | -$88.0K |
| M | 2025-02-21 | 2025-02-19+ | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale | $50.11 | -2,947 | 103.9K | -3% | -$147.7K |
| M | 2025-02-21 | 2025-02-19+ | PTCT | Klein Matthew B. | CEO, Dir | S - Sale | $50.11 | -7,792 | 276.0K | -3% | -$390.5K |
| M | 2025-02-21 | 2025-02-19+ | PTCT | Pauwels Eric | CEO | S - Sale | $50.11 | -2,945 | 85.4K | -3% | -$147.6K |
| M | 2025-02-21 | 2025-02-19+ | PTCT | Golden Lee Scott | EVP, Chief MEDICAL Off | S - Sale | $50.11 | -1,757 | 76.9K | -2% | -$88.0K |
| M | 2025-01-10 | 2025-01-07+ | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale | $44.87 | -3,541 | 106.8K | -3% | -$158.9K |
| MI | 2025-01-10 | 2025-01-07+ | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | S - Sale | $44.79 | -162 | 6,082 | -3% | -$7,255 |
| M | 2025-01-10 | 2025-01-07+ | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | S - Sale | $44.88 | -2,817 | 104.8K | -3% | -$126.4K |
| M | 2025-01-10 | 2025-01-07+ | PTCT | Pauwels Eric | CEO | S - Sale | $44.86 | -3,735 | 88.9K | -4% | -$167.6K |
| M | 2025-01-10 | 2025-01-07+ | PTCT | Golden Lee Scott | EVP, Chief MEDICAL Off | S - Sale | $44.84 | -2,008 | 78.7K | -2% | -$90.0K |
| M | 2025-01-10 | 2025-01-07+ | PTCT | Klein Matthew B. | CEO, Dir | S - Sale | $44.90 | -4,544 | 286.2K | -2% | -$204.0K |
| M | 2025-01-10 | 2025-01-07+ | PTCT | Utter Christine Marie | SVP, CAO | S - Sale | $44.87 | -2,953 | 64.3K | -4% | -$132.5K |
| D | 2025-01-07 | 2025-01-03 | PTCT | ZELDIS JEROME B | Dir | A - Grant | $0.00 | +4,000 | 18.5K | +28% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | Golden Lee Scott | EVP, Chief MEDICAL Off | A - Grant | $0.00 | +20.0K | 80.7K | +33% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | Young Alethia | Dir | A - Grant | $0.00 | +4,000 | 17.1K | +31% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | A - Grant | $0.00 | +19.0K | 106.0K | +22% | $0 |
| DI | 2025-01-07 | 2025-01-03 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | A - Grant | $0.00 | +715 | 6,137 | +13% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | Okey Stephanie | Dir | A - Grant | $0.00 | +4,000 | 13.9K | +41% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | STEELE GLENN JR MD PHD | Dir | A - Grant | $0.00 | +4,000 | 18.5K | +28% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | Smith Mary L. | Dir | A - Grant | $0.00 | +4,000 | 17.8K | +29% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | SCHMERTZLER MICHAEL | Dir | A - Grant | $0.00 | +8,000 | 131.3K | +6% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | Klein Matthew B. | CEO, Dir | A - Grant | $0.00 | +70.0K | 288.4K | +32% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | Utter Christine Marie | SVP, CAO | A - Grant | $0.00 | +14.0K | 67.3K | +26% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | Gravier Pierre | CFO | A - Grant | $0.00 | +22.5K | 76.8K | +41% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | Pauwels Eric | CEO | A - Grant | $0.00 | +22.0K | 90.5K | +32% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | Boulding Mark Elliott | EVP AND CLO | A - Grant | $0.00 | +18.0K | 110.4K | +19% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | Reeve Emma | Dir | A - Grant | $0.00 | +4,000 | 15.2K | +36% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | Jacobson Allan Steven | Dir | A - Grant | $0.00 | +4,000 | 20.3K | +24% | $0 |
| D | 2025-01-07 | 2025-01-03 | PTCT | SOUTHWELL DAVID P | Dir | A - Grant | $0.00 | +4,000 | 16.9K | +31% | $0 |
| 2025-01-03 | 2024-12-31 | PTCT | Klein Matthew B. | CEO, Dir | S - Sale | $45.16 | -8,279 | 217.5K | -4% | -$373.9K | |
| DMI | 2024-12-04 | 2024-12-02 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | S - Sale+OE | $51.97 | -2,060 | 4,853 | -30% | -$107.1K |
| DM | 2024-12-04 | 2024-12-02 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | M - OptEx | $51.00 | +69.5K | 88.8K | +361% | +$3.55M |
| DM | 2024-12-04 | 2024-12-02 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | S - Sale+OE | $52.06 | -69.5K | 86.2K | -45% | -$3.62M |
| DI | 2024-12-04 | 2024-12-02 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | M - OptEx | $51.00 | +2,060 | 6,636 | +45% | +$105.1K |
| DM | 2024-12-04 | 2024-12-02+ | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $52.37 | -95.9K | 92.5K | -51% | -$5.02M |
| DM | 2024-12-04 | 2024-12-02+ | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $49.07 | +95.9K | 176.0K | +120% | +$4.71M |
| DM | 2024-12-04 | 2024-12-02 | PTCT | Utter Christine Marie | SVP, CAO | S - Sale+OE | $51.77 | -17.8K | 53.0K | -25% | -$921.6K |
| DM | 2024-12-04 | 2024-12-02 | PTCT | Utter Christine Marie | SVP, CAO | M - OptEx | $51.00 | +17.8K | 55.5K | +47% | +$907.8K |
| DM | 2024-12-04 | 2024-12-02 | PTCT | ZELDIS JEROME B | Dir | M - OptEx | $40.93 | +24.0K | 26.5K | +960% | +$982.3K |
| DM | 2024-12-04 | 2024-12-02 | PTCT | ZELDIS JEROME B | Dir | S - Sale+OE | $51.50 | -24.0K | 14.5K | -62% | -$1.24M |
Purchase Sale Sale after option exercise All abbreviations